https://www.avient.com/news/avient-launches-new-bio-based-polymer-solutions-medical-and-pharmaceutical-applications-during-pharmapack-europe-2022
Like other Mevopur formulations, they are produced in dedicated facilities according to ISO 13485-2016 protocols and supported by testing to ISO 10993-1, USP, European Pharmacopeia and ICH Q3D guidelines.
https://www.avient.com/content/sds-iso-reach-rohs-ul
https://www.avient.com/news/avient-launches-new-density-modified-polymers-recycled-and-bio-based-content
POMMERLOCH, Luxembourg – January 23, 2023 – Today, Avient Corporation announced the expansion of its Gravi-Tech™ Density Modified Formulations portfolio to include more sustainable grades based on recycled and bio-based resin and/or filler, without sacrificing performance.
https://www.avient.com/news/avient-and-ivcc-accelerate-formulation-development-long-lasting-insecticidal-nets-malaria-control
POMMERLOCH, Luxembourg – April 23, 2021 – According to the World Health Organization, every year there are more than 200 million new cases of malaria, with children under 5 the most vulnerable group affected by the disease.
https://www.avient.com/news/new-lsfoh-formulation-avient-helps-prevent-environmental-stress-cracking-armored-cables
POMMERLOCH, Luxembourg – December 11, 2023 – Avient Corporation, a premier provider of specialized and sustainable material solutions and services, today announced the addition of a new grade to its ECCOH™ Low Smoke and Fume Non-Halogen Formulations portfolio.
https://www.avient.com/company/policies-and-governance/supplier-code-conduct
Global ISO Certificate Library
https://www.avient.com/products/polymer-additives/healthcare-additives/mevopur-healthcare-functional-additives
Global network of ISO 13485 certified manufacturing sites
ISO 10993-1, USP and (class VI), USP , European Pharmacopeia monographs 3.1.3 and 3.1.5, ICH Q3D evaluations reduce risk of non-compliance during regulatory submission
MEVOPUR™ ISO 6009 Standard/Customized Solutions met compliance requirements and improved quality for needle hub, cover and shield
https://www.avient.com/industries/healthcare/labware-diagnostics/laboratory-equipment
Color and special effect masterbatches pre-tested to ISO, US Pharmacopeia, European Pharmacopeia, and ICH Q3D protocols for identification and differentiation
Color and additive solutions based on biopolymers pre-tested to ISO, US Pharmacopeia, European Pharmacopeia, and ICHQ3D protocols to reduce product carbon footprint
Flexible, durable, and colorable TPEs for improved grips and gaskets that comply with USP Class VI and ISO 10993
https://www.avient.com/news/advanced-technologies-and-sustainable-material-innovations-avient-debut-chinaplas-2024
Mevopur™ Healthcare Colorants and Formulations: a range of medical grade concentrates and pre-colored formulations for a wide range of polymers used in applications such as remote patient monitoring, circulating blood contact, and invasive devices, with pre-tested biocompatibility according to ISO 10993, change control in place, production certified to ISO 13485-2016 and DMF/MAF files available
Colorant Chromatics™ Transcend™ Premier Healthcare Colorants: high-temperature solutions offered in pre-colored or concentrate form in a range of vivid opaque and transparent colors that are fully bio-compatible per ISO 10993 standards to provide ultra-high-heat resistance and performance without compromising safety
https://www.avient.com/news/specialty-healthcare-polymer-solutions-be-showcased-avient-mdm-west-2024
All Mevopur formulations are manufactured across a global network of ISO 13485 facilities, and they meet or exceed requirements for regulations such as USP Class VI, ISO 10993, USP 661, European Pharmacopeia, and ICH Q3D.
They are available in pre-colored or concentrate form in a range of vivid opaque and transparent colors that are fully bio-compatible per ISO 10993 standards.
